The Effects of Immunosuppressive Treatment During Pregnancy on the Levels of Potassium, Iron, Chromium, Zinc, Aluminum, Sodium and Molybdenum in Hard Tissues of Female Rats and Their Offspring

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Dec 2

PMID 33261165

Authors

Daniel Styburski

Wojciech Zwierello

Marta Skorka-Majewicz

Marta Goschorska

Irena Baranowska-Bosiacka

Joanna Kabat-Koperska

Dariusz Chlubek

Izabela Gutowska

Affiliations

Soon will be listed here.

Abstract

The ideal immunosuppressive regimen should provide for excellent immunosuppression with no side effects. Yet, current immunosuppressive therapy regimens commonly used in clinical applications fail to meet this criterion. One of the complications caused by immunosuppressive drugs is mineralization disorders in hard tissues. In this study, we evaluated the effects of three immunosuppressive therapies used after transplantation on the levels of potassium, iron, chromium, zinc, aluminum, sodium and molybdenum in the bones and teeth of female rats and their offspring. The study was conducted on 32 female Wistar rats, subjected to immunosuppressive regimens (cyclosporine A, mycophenolate mofetil and prednisone; tacrolimus, mycophenolate mofetil and prednisone; and cyclosporine A, everolimus and prednisone). The hard tissues of rats were analyzed using inductively coupled plasma optical emission spectrometry (ICP-OES, ICAP 7400 Duo, Thermo Scientific) equipped with a concentric nebulizer and a cyclonic spray chamber. All the immunosuppressive regimens included in the study affected the concentrations of the studied minerals in hard tissues of female rats and their offspring. The therapy based on cyclosporine A, everolimus and prednisone led to a decline in the levels of iron in bone, zinc in teeth, and molybdenum in the bone and teeth of mothers, while in the offspring, it caused a decline of bone potassium, with a decrease in iron and increase of molybdenum in teeth. Moreover, the regimen caused an increase in aluminum and chromium in the teeth and aluminum in the bones of the offspring, and consequently, it seems to be the therapy with the most negative impact on the mineral metabolism in hard tissues.

References

Maiorano A, Stallone G, Schena A, Infante B, Pontrelli P, Schena F . Sirolimus interferes with iron homeostasis in renal transplant recipients. Transplantation. 2006; 82(7):908-12. DOI: 10.1097/01.tp.0000235545.49391.1b. View

Soudani N, Ben Amara I, Troudi A, Bouaziz H, Boudawara T, Zeghal N . Oxidative stress induced by chromium (VI) in bone of suckling rats. Toxicol Ind Health. 2011; 27(8):724-34. DOI: 10.1177/0748233710395992. View

Martinez-Palli G, Hirose R, Liu T, Xu F, Dang K, Feiner J . Donor pre-treatment with everolimus or cyclosporine does not reduce ischaemia-reperfusion injury in a rat kidney transplant model. Nephrol Dial Transplant. 2010; 26(6):1813-20. DOI: 10.1093/ndt/gfq646. View

Ma Y, Kobayashi T, Kuzuya T, Liu D, Nagasaka T, Yokoyama I . Is absorption profile of cyclosporine really important for effective immunosuppression?. Biol Pharm Bull. 2006; 29(2):336-42. DOI: 10.1248/bpb.29.336. View

Vyskocil A, Viau C . Assessment of molybdenum toxicity in humans. J Appl Toxicol. 1999; 19(3):185-92. DOI: 10.1002/(sici)1099-1263(199905/06)19:3<185::aid-jat555>3.0.co;2-z. View

Yakupoglu H, Corsenca A, Wahl P, Wuthrich R, Ambuhl P . Posttransplant acidosis and associated disorders of mineral metabolism in patients with a renal graft. Transplantation. 2007; 84(9):1151-7. DOI: 10.1097/01.tp.0000287430.19960.0e. View

Jehle P, Jehle D, Mohan S, Keller F . Renal osteodystrophy: new insights in pathophysiology and treatment modalities with special emphasis on the insulin-like growth factor system. Nephron. 1998; 79(3):249-64. DOI: 10.1159/000045046. View

Weinstein R . Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med. 2011; 365(1):62-70. DOI: 10.1056/NEJMcp1012926. View

Al-Uzri A, Yorgin P, Kling P . Anemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis. Pediatr Transplant. 2003; 7(4):253-64. DOI: 10.1034/j.1399-3046.2003.00042.x. View

10.

Shah S, Verma P . Overview of Pregnancy in Renal Transplant Patients. Int J Nephrol. 2017; 2016:4539342. PMC: 5155089. DOI: 10.1155/2016/4539342. View

11.

Piao S, Bae S, Lim S, Song J, Chung B, Choi B . Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction. Transplantation. 2012; 93(4):383-9. DOI: 10.1097/TP.0b013e3182421604. View

12.

KATZ I, Takizawa M, Jaffe I, Stein B, Fallon M, Epstein S . Comparison of the effects of FK506 and cyclosporine on bone mineral metabolism in the rat. A pilot study. Transplantation. 1991; 52(3):571-4. View

13.

Viklicky O, Muller V, Zou H, Szabo A, Vitko S, Heemann U . RAD reduces compensatory renal graft hypertrophy in a rat model of chronic rejection. Transplant Proc. 2001; 33(3):2320-1. DOI: 10.1016/s0041-1345(01)02008-5. View

14.

Kaminska J, Sobiak J, Suliburska J, Duda G, Glyda M, Krejpcio Z . Effect of mycophenolate mofetil on plasma bioelements in renal transplant recipients. Biol Trace Elem Res. 2011; 145(2):136-43. PMC: 3272225. DOI: 10.1007/s12011-011-9178-7. View

15.

Jolicoeur E, Qi S, Xu D, Dumont L, Daloze P, Chen H . Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat. Transplantation. 2003; 75(1):54-9. DOI: 10.1097/00007890-200301150-00010. View

16.

Palacios C . The role of nutrients in bone health, from A to Z. Crit Rev Food Sci Nutr. 2006; 46(8):621-8. DOI: 10.1080/10408390500466174. View

17.

Molnar M, Naser M, Rhee C, Kalantar-Zadeh K, Bunnapradist S . Bone and mineral disorders after kidney transplantation: therapeutic strategies. Transplant Rev (Orlando). 2014; 28(2):56-62. PMC: 5588857. DOI: 10.1016/j.trre.2013.12.003. View

18.

Kurdian M, Herrero-Fresneda I, Lloberas N, Gimenez-Bonafe P, Coria V, Grande M . Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model. PLoS One. 2012; 7(3):e32516. PMC: 3299670. DOI: 10.1371/journal.pone.0032516. View

19.

Kabat-Koperska J, Kolasa-Wolosiuk A, Wojciuk B, Wojciechowska-Koszko I, Roszkowska P, Krasnodebska-Szponder B . The influence of intrauterine exposure to immunosuppressive treatment on changes in the immune system in juvenile Wistar rats. Drug Des Devel Ther. 2016; 10:2279-88. PMC: 4948737. DOI: 10.2147/DDDT.S102189. View

20.

Yamaguchi M . Role of nutritional zinc in the prevention of osteoporosis. Mol Cell Biochem. 2009; 338(1-2):241-54. DOI: 10.1007/s11010-009-0358-0. View